CHCT

Community Healthcare Trust Incorporated Real Estate - REIT - Healthcare Facilities Investor Relations →

YES
4.9% BELOW
↓ Approaching Was -2.5% last week
-15% -10% -5% 0% 5% 10% 15%+
Buy Threshold $19.25
14-Week RSI 66
Rel. Volume (14w) This week's trading vs. the 14-week average 1.2x
Buyers vs. Sellers (14w) Are up-weeks or down-weeks getting more volume? 0.94

Community Healthcare Trust Incorporated (CHCT) closed at $18.31 as of 2026-07-31, trading 4.9% below its 200-week moving average of $19.25. This places CHCT in the below line zone. The stock is currently moving closer to the line, down from -2.5% last week. The 14-week RSI sits at 66, indicating neutral momentum.

Trading volume is running at 1.2x of its 14-week average, which is in the normal range. The balance between buying and selling volume (0.94 ratio) is neutral — neither side is clearly dominating.

Over the past 536 weeks of data, CHCT has crossed below its 200-week moving average 4 times. On average, these episodes lasted 54 weeks. Historically, investors who bought CHCT at the start of these episodes saw an average one-year return of +25.0%.

With a market cap of $523 million, CHCT is a small-cap stock. The company generates a free cash flow yield of 14.8%, which is notably high. Return on equity stands at 1.4%. The stock trades at 1.2x book value.

Share count has increased 9.9% over three years, indicating dilution. This stock also meets the Yartseva multibagger criteria as a small-cap with strong free cash flow yield and reasonable book value.

Over the past 10.3 years, a hypothetical investment of $100 in CHCT would have grown to $193, compared to $427 for the S&P 500. CHCT has returned 6.6% annualized vs 15.1% for the index, underperforming the broader market over this period.

Free cash flow has been declining at a -10.4% compound annual rate. A deteriorating cash flow trend warrants extra scrutiny — the stock may be cheap for a reason.

Business Health

Annual financials — how the underlying business has performed over the past several years.

Cash Flow Free cash flow & net income ($M)

Revenue Annual revenue ($M) — business growth proxy

Total Debt Balance sheet debt ($M)

ROIC Return on invested capital (%)

FCF Yield Free cash flow / market cap (%) — Yartseva signal

Gross Margin Pricing power & competitive moat (%)

Shares Outstanding Buybacks vs dilution (millions)

Growth of $100: CHCT vs S&P 500

Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.

What Happens After CHCT Crosses Below the Line?

Across 4 historical episodes, buying CHCT when it crossed below its 200-week moving average produced an average return of +9.5% after 12 months (median +2.0%), compared to +26.2% for the S&P 500 over the same periods. 50% of those episodes were profitable after one year. After 24 months, the average return was -14.8% vs +51.8% for the index.

Each line shows $100 invested at the moment CHCT crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.

Bean Score Experimental

The Bean Score measures how far a stock's free cash flow yield has deviated from its own quarterly baseline, normalized by the stock's historical behavior. Between earnings dates, FCF is constant — so the score is purely a function of stock price. The levels below show at what prices CHCT would reach each dislocation threshold.

Current Bean Score -1.79σ
Current FCF Yield 6.68%
Baseline Yield 7.82%
Historical σ 0.34pp

Dislocation Price Levels

Prices where CHCT's Bean Score would hit each σ threshold. Valid until next earnings report (date TBD — last report: 2026-03-31).

LevelσPriceSignal
Deep Value+2σ$15.38Unusually cheap — potential buy zone
Value+1σ$16.06Cheap vs. own history
Fair Value+0σ$16.80Historical mean behavior
Expensive-1σ$17.61Expensive vs. own history
Deep Expensive-2σ$18.50Unusually expensive — potential trim zone

Quarterly FCF & Yield Trailing twelve-month free cash flow and yield at each quarter end

Data depth: 2 quarterly baselines, 26 price observations — Limited history (4+ quarters preferred for reliability)

Signal Accuracy Collecting Data

The Bean Score system is accumulating weekly data to validate signal accuracy. After 13+ weeks of history, this section will display win rates and average returns for each σ threshold crossing — answering the question: "When this score says cheap or expensive, does the price subsequently move in the expected direction?"

12 / 13 weeks minimum

Theoretical framework — not backtested or forward-tested. The Bean Score uses trailing twelve-month free cash flow yield as a dislocation identifier. It measures whether the market has pushed a stock's yield unusually far from its own baseline behavior. These levels are reference points for identifying potential swing trade opportunities, not buy/sell signals. FCF values update quarterly with earnings; between reports, all movement is price-driven.

Dislocation Scores Experimental

Each score measures deviation from CHCT's own historical baseline — the same idea as the Bean Score, applied to different fundamentals. Positive means cheaper or more dislocated than this stock's norm. Scores marked σ are normalized by the stock's own variability; pp values are simple deltas from its recent baseline.

⚠ Earnings quality deteriorating — net income is outrunning free cash flow vs this company's own norm. Cheapness signals here deserve extra scrutiny.
Yield Dislocation +0.75σ Dividend yield vs own 10-yr norm
Drawdown Score +0.51σ Distance from line vs own history
Sector-Relative N/A Vs sector median this week
Buyback Acceleration -2.4pp YoY share change vs own 3-yr pace (− = accelerating)
Insider Intensity 52th TTM buys / market cap, percentile of buyers
FCF Yield vs History +7.4pp Vs own recent annual mean
Earnings Quality Deteriorating Accrual gap trend (+5.1pp of revenue)

Theoretical framework — not backtested. These scores describe how unusual today's readings are for this specific company. They are starting points for research, not buy or sell signals. Annual-statement scores (buyback, accruals, FCF vs history) rest on only ~4 yearly data points and are deltas, not sigmas.

Historical Touches

CHCT has crossed below its 200-week MA 4 times with an average 1-year return of +25.0% after recovery.

Crossed BelowRecoveredWeeksMax Depth1-Year ReturnReturn Since Touch
Mar 2020Mar 202017.3%+83.1%+7.5%
Apr 2022Aug 20221414.8%+1.9%-29.6%
Aug 2022Jan 20232020.8%-10.1%-33.4%
Feb 2023Ongoing179+50.4%Ongoing-36.2%
Average54+25.0%

Frequently Asked Questions

Is CHCT below its 200-week moving average?

Yes. As of 2026-07-31, Community Healthcare Trust Incorporated (CHCT) is trading 4.9% below its 200-week moving average of $19.25. The current price is $18.31.

What is CHCT's 200-week moving average price?

Community Healthcare Trust Incorporated's 200-week moving average is $19.25 as of 2026-07-31. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.

What happens when CHCT drops below its 200-week moving average?

CHCT has crossed below its 200-week moving average 4 times in our data. On average, buying at that moment produced a one-year return of +25.0%. These dips have historically been decent entry points. These episodes lasted 54 weeks on average.

Is CHCT a good value right now?

Here's what our data says about CHCT as of 2026-07-31: The stock is below its 200-week moving average, which is the starting point for our analysis. The 14-week RSI is 66. Free cash flow yield is 14.8%. Return on equity is 1.4%. Price-to-book is 1.2x. This is not a buy or sell recommendation — always do your own research.

How does CHCT compare to the S&P 500?

Over the past 10.3 years, $100 invested in CHCT would have grown to $193, compared to $427 for the S&P 500. That's 6.6% annualized vs 15.1% for the index. CHCT has underperformed the broader market over this period.

Does CHCT pay a dividend?

Yes. Community Healthcare Trust Incorporated currently pays a dividend yield of 1026.00%.

Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.

Data as of week of 2026-07-31